|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
1
|
Resverlogix Corp.
|
Aug 10, 2019 09:21PM
|
|
New article epigenetics
|
3
|
Resverlogix Corp.
|
Aug 10, 2019 10:09PM
|
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
|
Resverlogix Corp.
|
Aug 12, 2019 08:04AM
|
|
Re: Eastern
|
3
|
Resverlogix Corp.
|
Aug 13, 2019 09:50AM
|
|
Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
|
6
|
Resverlogix Corp.
|
Aug 14, 2019 09:23AM
|
|
Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
|
2
|
Resverlogix Corp.
|
Aug 14, 2019 12:26PM
|
|
Did IR ever say RVX would be announcing DBL
|
1
|
Resverlogix Corp.
|
Aug 14, 2019 01:30PM
|
|
Re: Peter Libby / You Tube Interview
|
3
|
Resverlogix Corp.
|
Aug 16, 2019 08:51AM
|
|
Re: Peter Libby / You Tube Interview
|
5
|
Resverlogix Corp.
|
Aug 16, 2019 09:14AM
|
|
Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
|
4
|
Resverlogix Corp.
|
Aug 16, 2019 11:34AM
|
|
Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
|
|
Resverlogix Corp.
|
Aug 17, 2019 07:35AM
|
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Aug 18, 2019 01:57PM
|
|
Re: Anyone else find it odd......
|
4
|
Resverlogix Corp.
|
Aug 19, 2019 01:02PM
|
|
Re: Publication / Resverlogix An Author
|
2
|
Resverlogix Corp.
|
Aug 20, 2019 10:49AM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
1
|
Resverlogix Corp.
|
Aug 22, 2019 09:00PM
|
|
Re: TLD Confidence
|
2
|
Resverlogix Corp.
|
Aug 26, 2019 09:36AM
|
|
Re: Why worry about the Third Eye loan?
|
|
Resverlogix Corp.
|
Aug 28, 2019 08:36AM
|
|
Re: Signing Off
|
|
Resverlogix Corp.
|
Aug 28, 2019 12:52PM
|
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
2
|
Resverlogix Corp.
|
Aug 29, 2019 07:07AM
|
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
1
|
Resverlogix Corp.
|
Aug 29, 2019 08:14AM
|
